Calnexin deficiency leads to dysmyelination

Allison Kraus, Jody Groenendyk, Karen Bedard, Troy A. Baldwin, Karl Heinz Krause, Michel Dubois-Dauphin, Jason Dyck, Erica E. Rosenbaum, Lawrence Korngut, Nansi J. Colley, Simon Gosgnach, Douglas Zochodne, Kathryn Todd, Luis B. Agellon, Marek Michalak

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

62 Citas (Scopus)

Resumen

Calnexin is a molecular chaperone and a component of the quality control of the secretory pathway. We have generated calnexin gene-deficient mice (cnx -/-) and showed that calnexin deficiency leads to myelinopathy. Calnexin-deficient mice were viable with no discernible effects on other systems, including immune function, and instead they demonstrated dysmyelination as documented by reduced conductive velocity of nerve fibers and electron microscopy analysis of sciatic nerve and spinal cord. Myelin of the peripheral and central nervous systems of cnx-/- mice was disorganized and decompacted. There were no abnormalities in neuronal growth, no loss of neuronal fibers, and no change in fictive locomotor pattern in the absence of calnexin. This work reveals a previously unrecognized and important function of calnexin in myelination and provides new insights into the mechanisms responsible for myelin diseases.

Idioma originalEnglish
Páginas (desde-hasta)18928-18938
Número de páginas11
PublicaciónJournal of Biological Chemistry
Volumen285
N.º24
DOI
EstadoPublished - jun. 11 2010
Publicado de forma externa

ASJC Scopus Subject Areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Huella

Profundice en los temas de investigación de 'Calnexin deficiency leads to dysmyelination'. En conjunto forman una huella única.

Citar esto